"Glyphosate exposure does not cause cancer."
Evidence6
The European Chemicals Agency said glyphosate does not meet EU criteria to be classified as cancer-causing.
In 2022, the European Chemicals Agency Committee for Risk Assessment reviewed human, animal, and mechanistic evidence for glyphosate.
The committee kept glyphosate classified for serious eye damage and aquatic toxicity, but did not classify it as carcinogenic.
This is a hazard-classification decision and is widely used in EU chemical regulation.
In 2022, the European Chemicals Agency Committee for Risk Assessment reviewed human, animal, and mechanistic evidence for glyphosate.
The committee kept glyphosate classified for serious eye damage and aquatic toxicity, but did not classify it as...
The U.S. National Cancer Institute reports mixed findings, with large cohort data not showing an overall glyphosate cancer increase.
The U.S. National Cancer Institute summarizes multiple studies on glyphosate and cancer risk.
Its review notes that findings are mixed across study designs, and that one of the largest cohort datasets did not show an overall cancer increase from glyphosate exposure.
This source is useful as an official synthesis rather than a single study result.
The U.S. National Cancer Institute summarizes multiple studies on glyphosate and cancer risk.
Its review notes that findings are mixed across study designs, and that one of the largest cohort datasets did not show an overall cancer increase from glyphosate...
The U.S. EPA concluded glyphosate is not likely to be carcinogenic to humans at exposures relevant to current labeled uses.
The U.S. Environmental Protection Agency reviewed glyphosate in its human-health risk assessment and interim registration review decisions.
EPA reported that available evidence did not support classifying glyphosate as a human carcinogen at expected real-world exposure levels from approved uses.
This conclusion differs from some hazard-focused evaluations and reflects EPA''s risk-based approach using exposure assumptions for labeled use.
The U.S. Environmental Protection Agency reviewed glyphosate in its human-health risk assessment and interim registration review decisions.
EPA reported that available evidence did not support classifying glyphosate as a human carcinogen at expected...
EFSA's 2023 EU peer review reported no critical areas of concern for glyphosate carcinogenicity, while identifying some remaining data gaps.
The European Food Safety Authority published conclusions from the EU renewal review process for glyphosate.
EFSA stated it did not identify critical areas of concern that would block renewal on cancer grounds, but it did note some unresolved data gaps.
This position aligns with recent EU regulator assessments that did not classify glyphosate as carcinogenic.
The European Food Safety Authority published conclusions from the EU renewal review process for glyphosate.
EFSA stated it did not identify critical areas of concern that would block renewal on cancer grounds, but it did note some unresolved data gaps.
This position aligns with recent EU regulator assessments that did not classify glyphosate as carcinogenic.
Health Canada reported that, after reviewing over 1,300 studies and sources, glyphosate is unlikely to pose a human cancer risk at approved exposure levels.
Health Canada published a detailed response after reevaluating glyphosate and reviewing a large evidence package.
The agency stated it considered more than 1,300 studies and information sources.
Its conclusion was that glyphosate is unlikely to pose a human cancer risk at levels people encounter when products are used as directed.
Health Canada published a detailed response after reevaluating glyphosate and reviewing a large evidence package.
The agency stated it considered more than 1,300 studies and information sources.
Its conclusion was that glyphosate is unlikely to pose a...
In 54,251 licensed pesticide applicators followed for about 20 years, researchers found no overall increase in solid tumors or non-Hodgkin lymphoma from glyphosate use.
This update from the Agricultural Health Study is one of the largest prospective datasets on glyphosate exposure.
It followed 54,251 licensed pesticide applicators and examined cancer incidence across many sites.
The study did not find clear overall increases in solid tumors or non-Hodgkin lymphoma. It reported one possible signal for acute myeloid leukemia in the highest exposure group, but the number of cases in that subgroup was small.
This update from the Agricultural Health Study is one of the largest prospective datasets on glyphosate exposure.
It followed 54,251 licensed pesticide applicators and examined cancer incidence across many sites.
The study did not find clear overall...